Terms: = Breast cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Prognosis
44 results:
1. Antiproliferative activities of some selected Nigerian medicinal plants against breast, liver, and cervical cancer cells.
Olaleye OO; Kim DH; Spriggs KA
BMC Complement Med Ther; 2024 Mar; 24(1):110. PubMed ID: 38448883
[TBL] [Abstract] [Full Text] [Related]
2. CDK9 Inhibitor Induces Apoptosis, Autophagy, and Suppression of Tumor Growth in Adult T-Cell Leukemia/Lymphoma.
Kato N; Kozako T; Ohsugi T; Uchida Y; Yoshimitsu M; Ishitsuka K; Aikawa A; Honda SI
Biol Pharm Bull; 2023; 46(9):1269-1276. PubMed ID: 37661406
[TBL] [Abstract] [Full Text] [Related]
3. Rutaecarpine induces the differentiation of triple-negative breast cancer cells through inhibiting fumarate hydratase.
Lei J; Pan Y; Gao R; He B; Wang Z; Lei X; Zhang Z; Yang N; Yan M
J Transl Med; 2023 Aug; 21(1):553. PubMed ID: 37592347
[TBL] [Abstract] [Full Text] [Related]
4. Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma.
Wang ML; Jurczak W; Zinzani PL; Eyre TA; Cheah CY; Ujjani CS; Koh Y; Izutsu K; Gerson JN; Flinn I; Tessoulin B; Alencar AJ; Ma S; Lewis D; Lech-Maranda E; Rhodes J; Patel K; Maddocks K; Lamanna N; Wang Y; Tam CS; Munir T; Nagai H; Hernandez-Ilizaliturri F; Kumar A; Fenske TS; Seymour JF; Zelenetz AD; Nair B; Tsai DE; Balbas M; Walgren RA; Abada P; Wang C; Zhao J; Mato AR; Shah NN
J Clin Oncol; 2023 Aug; 41(24):3988-3997. PubMed ID: 37192437
[TBL] [Abstract] [Full Text] [Related]
5. 1'-Acetoxychavicol Acetate from Alpinia galanga Represses Proliferation and Invasion, and Induces Apoptosis via HER2-signaling in Endocrine-Resistant breast cancer Cells.
Pradubyat N; Giannoudis A; Elmetwali T; Mahalapbutr P; Palmieri C; Mitrpant C; Ketchart W
Planta Med; 2022 Feb; 88(2):163-178. PubMed ID: 33445186
[TBL] [Abstract] [Full Text] [Related]
6. A Cyclin D1-Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma.
Demajo S; Albero R; Clot G; Castellano G; Navarro A; Capdevila C; Enjuanes A; Nadeu F; Giné E; Pinyol M; Jaffe ES; Ott G; Staudt LM; Rosenwald A; Scott DW; Rimsza LM; López-Guillermo A; Beà S; Campo E; Jares P
Clin Cancer Res; 2021 Jan; 27(1):213-225. PubMed ID: 33046520
[TBL] [Abstract] [Full Text] [Related]
7. Pyrrolo [3,4-
Wang D; Nie Z; Jiang X; Ye J; Wei Z; Cheng D; Wang C; Wu Y; Liu R; Chen H; Chen C; Wang C
Aging (Albany NY); 2020 May; 12(10):9621-9632. PubMed ID: 32452831
[TBL] [Abstract] [Full Text] [Related]
8. Revisiting the Genomic and Transcriptomic Landscapes from Female Malignancies Could Provide Molecular Markers and Targets for Precision Medicine.
Taniguchi-Ponciano K; Huerta-Padilla V; Baeza-Xochihua V; Ponce-Navarrete G; Salcedo E; Gomez-Apo E; Chavez-Macias L; Aviles-Duran J; Ruiz-Sanchez H; Valdivia A; Peralta R; Romero-Anduaga H; Rosas-Vargas H; Quijano F; Salcedo M; Marrero-Rodríguez D
Arch Med Res; 2019 Oct; 50(7):428-436. PubMed ID: 31783305
[TBL] [Abstract] [Full Text] [Related]
9. Regulation of mcl-1 alternative splicing by hnRNP F, H1 and K in breast cancer cells.
Tyson-Capper A; Gautrey H
RNA Biol; 2018; 15(12):1448-1457. PubMed ID: 30468106
[TBL] [Abstract] [Full Text] [Related]
10. Streamlining Decision Making in Contralateral Risk-Reducing Mastectomy: Impact of PREDICT and BOADICEA Computations.
de Silva TS; Russell VR; Henry FP; Thiruchelvam PTR; Hadjiminas DJ; Al-Mufti R; Hogben RK; Hunter J; Wood S; Jallali N; Leff DR
Ann Surg Oncol; 2018 Oct; 25(10):3057-3063. PubMed ID: 30019305
[TBL] [Abstract] [Full Text] [Related]
11. BRCAness Combined With a Family History of cancer Is Associated With a Poor prognosis for breast cancer Patients With a High Risk of BRCA Mutations.
Mori H; Kubo M; Kai M; Velasquez VV; Kurata K; Yamada M; Okido M; Kuroki S; Oda Y; Nakamura M
Clin Breast Cancer; 2018 Oct; 18(5):e1217-e1227. PubMed ID: 29941390
[TBL] [Abstract] [Full Text] [Related]
12. Inhibitory effects of isocryptotanshinone on gastric cancer.
Chen ZM; Huang L; Li MM; Meng L; Ying SC; Xu AM
Sci Rep; 2018 Jun; 8(1):9307. PubMed ID: 29915371
[TBL] [Abstract] [Full Text] [Related]
13. Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history.
Meiser B; Quinn VF; Mitchell G; Tucker K; Watts KJ; Rahman B; Peate M; Saunders C; Geelhoed E; Gleeson M; Barlow-Stewart K; Field M; Harris M; Antill YC; Susman R; Bowen MT; Mills L; Kirk J;
Eur J Hum Genet; 2018 Jul; 26(7):972-983. PubMed ID: 29599518
[TBL] [Abstract] [Full Text] [Related]
14. mcl-1 is a prognostic indicator and drug target in breast cancer.
Campbell KJ; Dhayade S; Ferrari N; Sims AH; Johnson E; Mason SM; Dickson A; Ryan KM; Kalna G; Edwards J; Tait SWG; Blyth K
Cell Death Dis; 2018 Jan; 9(2):19. PubMed ID: 29339815
[TBL] [Abstract] [Full Text] [Related]
15. Male breast cancer and mantle cell lymphoma in a single patient: A case report and literature review.
Liu J; Wei H; Zhu K; Lai L; Han X; Yang Y
Medicine (Baltimore); 2017 Dec; 96(48):e8911. PubMed ID: 29310379
[TBL] [Abstract] [Full Text] [Related]
16. Discovery of a potent inhibitor of MELK that inhibits expression of the anti-apoptotic protein mcl-1 and TNBC cell growth.
Edupuganti R; Taliaferro JM; Wang Q; Xie X; Cho EJ; Vidhu F; Ren P; Anslyn EV; Bartholomeusz C; Dalby KN
Bioorg Med Chem; 2017 May; 25(9):2609-2616. PubMed ID: 28351607
[TBL] [Abstract] [Full Text] [Related]
17. RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment.
Hein AL; Post CM; Sheinin YM; Lakshmanan I; Natarajan A; Enke CA; Batra SK; Ouellette MM; Yan Y
Oncogene; 2016 Dec; 35(49):6319-6329. PubMed ID: 27181206
[TBL] [Abstract] [Full Text] [Related]
18. A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant cancers.
Karpel-Massler G; Horst BA; Shu C; Chau L; Tsujiuchi T; Bruce JN; Canoll P; Greene LA; Angelastro JM; Siegelin MD
Clin Cancer Res; 2016 Sep; 22(18):4698-711. PubMed ID: 27126996
[TBL] [Abstract] [Full Text] [Related]
19. The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer.
Pandya V; Glubrecht D; Vos L; Hanson J; Damaraju S; Mackey J; Hugh J; Goping IS
Oncotarget; 2016 May; 7(22):33272-85. PubMed ID: 27120789
[TBL] [Abstract] [Full Text] [Related]
20. mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications.
Bashari MH; Fan F; Vallet S; Sattler M; Arn M; Luckner-Minden C; Schulze-Bergkamen H; Zörnig I; Marme F; Schneeweiss A; Cardone MH; Opferman JT; Jäger D; Podar K
Breast Cancer Res; 2016 Feb; 18(1):26. PubMed ID: 26921175
[TBL] [Abstract] [Full Text] [Related]
[Next]
